Assessment of Asymptomatically Increased CA 19-9.
10.15279/kpba.2017.22.3.114
- Author:
Jaihwan KIM
1
Author Information
1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. drjaihwan@snu.ac.kr
- Publication Type:Review
- Keywords:
Pancreatic neoplasms;
Biomarkers;
Tumor;
Early detection of cancer;
CA 19-9 antigen
- MeSH:
Biomarkers;
Biomarkers, Tumor;
CA-19-9 Antigen;
Delivery of Health Care;
Early Detection of Cancer;
Humans;
Incidence;
Korea;
Mass Screening;
Pancreatic Neoplasms;
Prognosis
- From:Korean Journal of Pancreas and Biliary Tract
2017;22(3):114-117
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Health care screening is becoming more popular in Korea as more people are interested in well-being and health. However, there are controversies regarding usefulness of screening. Tumor markers are frequently measured in the health care screening. As a result, many patients end up visiting physicians because of incidentally found increased levels of tumor markers. Carbohydrate antigen (CA) 19-9 is the single most useful tumor marker for pancreatic cancer. Although CA 19-9 is useful for predicting prognosis and evaluating treatment response for pancreatic cancer, CA 19-9 is less useful for screening of pancreatic cancer because of low incidence of pancreatic cancer.
